July 8, 2016
On July 1, 2016, Dr. Jon I. Einarsson ascended to the role of President of the AAGL, taking the place of immediate past president Dr. Arnold P. Advincula. We would like to thank Dr. Advincula for his 18 months of service as the AAGL President, and congratulate Dr. Einarsson as he takes on this new role.
Dr. Einarsson is the Founder and Director of the Division of Minimally Invasive Gynecologic Surgery at Brigham and Women’s Hospital (BWH) and an Associate Professor of Obstetrics, Gynecology and Reproductive Medicine at Harvard Medical School in Boston. His extensive involvement with the AAGL began with his 2-year MIGS fellowship at Baylor College of Medicine. Dr. Einarsson established an AAGL/SRS FMIGS Fellowship program at BWH in 2008. He has served as chair of the annual AAGL Comprehensive Workshop in MIGS for Residents, Fellows and New MIG Specialists for the past two years, and was the Scientific Program Chair for the AAGL Global Congress in 2015. ( READ MORE )
July 7, 2016
As recently announced in NewsScope, the AAGL Nominations Committee will soon select eight members of the AAGL as candidates for four trustee positions for the years 2017 and 2018.
Four of the candidates will be from the general membership and four must come from specific regions. This year, two candidates will be from Europe, Russia, Middle East, or Africa, and two from Canada and the United States.
In addition, two other members will be selected from the general membership to run as candidates for the position of Secretary-Treasurer. This position leads to Vice Presidency and then the Presidency of the AAGL. Please note that candidates for Secretary-Treasurer must have previously served on the Board. ( READ MORE )
From the Desk of the AAGL President – Advisory Statement on Essure and AUGS Position Statement on Midurethral SlingsJune 29, 2016
As many of you know, in the preceding months there have been communications from the FDA and numerous societal discussions as it relates to two very important surgical devices in our gynecologic armamentarium: the Essure for hysteroscopic sterilization and the mesh midurethral slings for stress urinary incontinence. This recent focus on two of our minimally invasive surgical treatments is consistent with the fact that the surgical healthcare landscape in gynecology has continued to come under fire over the last several years. Patient concerns, medico-legal targeting, and public misinformation have driven much of the scrutiny.
As a result, I would like to bring to your attention two very important documents. The first is our AAGL Advisory Statement on the Essure device. It was developed with the intent to provide an unbiased, evidence-based view of the critical aspects of hysteroscopic sterilization. The second is a joint position statement developed by AUGS and SUFU in order to justify the use of the mesh midurethral sling in the surgical management of stress urinary incontinence. This position statement, which outlines very nicely the safety and effectiveness of mesh midurethral slings, has been endorsed by the AAGL. ( READ MORE )